Home / KALA : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does KALA make money? Does KALA have pricing power? What's the Earnings Whisper? Will KALA profit more as the business scales? What is KALA's management track record? Is KALA's current price justified?

KALA BIO, Inc.

$0.57 -$30.49 (-98.16%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$0.56

Day Range

$0.57$0.6

Year Range

$0.49$1030

Market Cap

11.07M

AVG Volume

266.62K

Trailing/Forward PE

-0.01/-

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-10

Primary Exchange

NASDAQ

Revenue (USD)

KALA Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	0
24 Q3	0
24 Q2	0
24 Q1	0

Net Income (USD)

KALA Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-1.58M
26 Q1	-1.62M
25 Q4	686K
25 Q3	-7.56M
25 Q2	-11.15M
25 Q1	-8.95M
24 Q4	-8.18M
24 Q3	-8.95M
24 Q2	-9.58M
24 Q1	-11.81M

Operating Income (USD)

KALA Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-1.72M
26 Q1	-1.8M
25 Q4	-10.22M
25 Q3	-7.24M
25 Q2	-11.03M
25 Q1	-10.67M
24 Q4	-9.46M
24 Q3	-9.57M
24 Q2	-9.63M
24 Q1	-11.77M

EBITDA (USD)

KALA EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	-1.58M
26 Q1	-1.62M
25 Q4	881K
25 Q3	-6.47M
25 Q2	-10.01M
25 Q1	-7.79M
24 Q4	-6.71M
24 Q3	-7.41M
24 Q2	-8.06M
24 Q1	-10.29M

Cash Flows (USD)

KALA Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	-1.53M
26 Q1	-2.9M
25 Q4	-4.57M
25 Q3	-10.86M
25 Q2	-7.73M
25 Q1	-8.82M
24 Q4	-4.67M
24 Q3	-4.68M
24 Q2	-9.25M
24 Q1	-10.86M

EPS (USD)

KALA EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-21.32
26 Q1	-7
25 Q4	0
25 Q3	-53.5
25 Q2	-85.5
25 Q1	-70.49
24 Q4	-1.74
24 Q3	-1.93
24 Q2	-3.16
24 Q1	-4.2

Expenses (USD)

KALA Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	1.72M
26 Q1	1.8M
25 Q4	10.19M
25 Q3	10.64M
25 Q2	10.89M
25 Q1	10.65M
24 Q4	9.46M
24 Q3	9.46M
24 Q2	9.61M
24 Q1	11.72M

Cash & Debt (USD)

KALA Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	7.23M
26 Q1	8.76M
25 Q4	7.56M
25 Q3	21.1M
25 Q2	31.94M
25 Q1	42.22M
24 Q4	51.18M
24 Q3	49.2M
24 Q2	54.2M
24 Q1	48.48M

Debt ratios

KALA Debt ratios by quarter
Period	Debt ratios
26 Q2	0.82
26 Q1	0.51
25 Q4	0.32
25 Q3	-0.29
25 Q2	0.06
25 Q1	0.33
24 Q4	0.58
24 Q3	0.37
24 Q2	0.53
24 Q1	0.36

Margins

KALA Margins by quarter
Period	Margins
22 Q3	57.14%
22 Q2	15.52%
22 Q1	43.51%
21 Q4	23.6%
21 Q3	70.39%
21 Q2	66.7%
21 Q1	69.29%
20 Q4	29.22%
20 Q3	59.1%
20 Q2	-75.51%

Return on Capital

KALA Return on Capital by quarter
Period	Return on Capital
26 Q2	-17.48%
26 Q1	-15.06%
25 Q4	9.81%
25 Q3	87.29%
25 Q2	347.94%
25 Q1	-156.74%
24 Q4	-66.29%
24 Q3	-130.49%
24 Q2	-69.83%
24 Q1	-177.26%

Shares Outstanding

KALA Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	74.16K
26 Q1	237.47K
25 Q4	0
25 Q3	140.85K
25 Q2	130.26K
25 Q1	126.92K
24 Q4	4.69M
24 Q3	4.63M
24 Q2	3.03M
24 Q1	2.81M

Book Value Per Share (USD)

KALA Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	121.95
26 Q1	45.32
25 Q3	-61.52
25 Q2	-24.61
25 Q1	44.97
24 Q4	2.63
24 Q3	1.48
24 Q2	4.53
24 Q1	2.37
23 Q4	2.77

Total Assets (USD)

KALA Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	10.58M
26 Q1	12.32M
25 Q4	9.49M
25 Q3	25.02M
25 Q2	36.05M
25 Q1	48.25M
24 Q4	55.48M
24 Q3	54.08M
24 Q2	61.61M
24 Q1	53.03M

Employee Count

KALA Employee Count by quarter
Period	Employee Count
2025	6
2024	38
2023	43
2022	34
2021	192
2020	188
2019	136
2018	130
2017	37

Free Cash Flow Yield

KALA Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-46793.05%
Sep 26	-52797.84%
Aug 26	-38812.26%
Aug 26	-32659.85%
Aug 26	-11607.42%
Aug 26	-14676.14%
Jul 26	-14518.87%
Jul 26	-17304.97%
Jul 26	-14146.45%
Jul 26	-9300.69%
Jul 26	-6532.63%
Jun 26	-4355.08%
Jun 26	-3040.11%
Jun 26	-4172.93%
Jun 26	-5327.58%
May 26	-4921.44%
May 26	-4516.38%
May 26	-3745.67%
Apr 26	-2244.38%
Apr 26	-2676.9%
Mar 26	-2594.58%
Mar 26	-1924.02%
Mar 26	-1627.17%
Mar 26	-1638.88%
Feb 26	-1198.97%
Feb 26	-1198.97%
Feb 26	-1120.53%
Feb 26	-1035.47%
Jan 26	-859.64%
Jan 26	-753.07%
Jan 26	-674.98%
Jan 26	-721.36%
Jan 26	-733.43%
Dec 25	-700.94%
Dec 25	-732.25%
Dec 25	-674.78%
Dec 25	-506.23%
Nov 25	-471.55%
Nov 25	-734.85%
Nov 25	-563.12%
Nov 25	-557.12%
Oct 25	-509.84%
Oct 25	-499.72%
Oct 25	-303.57%
Oct 25	-278.09%
Oct 25	-258.23%
Sep 25	-20.88%
Sep 25	-20.26%
Sep 25	-21.36%
Sep 25	-27.33%
Aug 25	-35.44%
Aug 25	-43.18%
Aug 25	-47.8%
Aug 25	-53.89%
Aug 25	-57.61%
Jul 25	-53.41%
Jul 25	-75.27%
Jul 25	-73.86%
Jul 25	-84.72%
Jun 25	-93.52%
Jun 25	-106.95%
Jun 25	-100.48%
Jun 25	-104.36%
May 25	-116.15%
May 25	-106.95%
May 25	-117.73%
May 25	-3.67%
May 25	-3.35%
Apr 25	-3.95%
Apr 25	-3.63%
Apr 25	-3.72%
Apr 25	-2.96%
Mar 25	-2.32%
Mar 25	-2.03%
Mar 25	-2.14%
Mar 25	-1.99%
Feb 25	-2.03%
Feb 25	-2.11%
Feb 25	-1.68%
Feb 25	-1.27%
Jan 25	-1.53%
Jan 25	-1.73%
Jan 25	-1.94%
Jan 25	-2.06%
Jan 25	-1.77%
Dec 24	-2.01%
Dec 24	-2.37%
Dec 24	-2.27%
Dec 24	-2.07%
Nov 24	-2.05%
Nov 24	-2.07%
Nov 24	-2.1%
Nov 24	-2.69%
Nov 24	-2.93%
Oct 24	-3.01%
Oct 24	-3.94%
Oct 24	-3.89%
Oct 24	-3.79%
Sep 24	-3.83%
Sep 24	-3.54%

Price to Sales

KALA Price to Sales by quarter
Period	Price to Sales
Nov 23	1583.33
Nov 23	1989.83
Oct 23	1938.66
Oct 23	2092.16
Oct 23	2322.36
Oct 23	2518.5
Sep 23	2529.92
Sep 23	2940.51
Sep 23	3021.7
Sep 23	3146.77
Sep 23	3755.09
Aug 23	3865.95
Aug 23	3880.16
Aug 23	3826.15
Aug 23	4013.77
Jul 23	608.44
Jul 23	604.74
Jul 23	592.43
Jul 23	613.37
Jun 23	599
Jun 23	603.92
Jun 23	593.25
Jun 23	594.48
Jun 23	678.23
May 23	617.88
May 23	681.11
May 23	668.38
May 23	299.28
Apr 23	308.07
Apr 23	307.68
Apr 23	324.87
Apr 23	269.58
Mar 23	294
Mar 23	304.16
Mar 23	270.76
Mar 23	368.24
Mar 23	327.21
Feb 23	149.95
Feb 23	165.99
Feb 23	192.07
Feb 23	229.23
Jan 23	256.22
Jan 23	237.97
Jan 23	255.83
Jan 23	383.23
Dec 22	497.45
Dec 22	50.59
Dec 22	55.03
Dec 22	65.2
Dec 22	65.46
Nov 22	74.85
Nov 22	80.45
Nov 22	91.14
Nov 22	46.11
Oct 22	53.71
Oct 22	70.21
Oct 22	110.14
Oct 22	118.48
Sep 22	97.15
Sep 22	110.93
Sep 22	136.03
Sep 22	149.85
Sep 22	147.49
Aug 22	128.48
Aug 22	136.03
Aug 22	147.49
Aug 22	133.75
Jul 22	130.01
Jul 22	131.82
Jul 22	133.91
Jul 22	133.63
Jul 22	117.32
Jun 22	142.38
Jun 22	154.71
Jun 22	142.58
Jun 22	149.71
May 22	138.24
May 22	254.7
May 22	197.81
May 22	226.64
Apr 22	187.95
Apr 22	216.74
Apr 22	246.72
Apr 22	298.05
Apr 22	379.08
Mar 22	514.94
Mar 22	436.58
Mar 22	472.96
Mar 22	174.02
Feb 22	190.08
Feb 22	200.16
Feb 22	199.51
Feb 22	220.53
Jan 22	220.78
Jan 22	226.83
Jan 22	291.05
Jan 22	302.25
Dec 21	338.63
Dec 21	380.61
Dec 21	391.8

Price to Book

KALA Price to Book by quarter
Period	Price to Book
Sep 26	0
Sep 26	0
Aug 26	0.01
Aug 26	0.01
Aug 26	0.02
Aug 26	0.02
Jul 26	0.02
Jul 26	0.01
Jul 26	0.02
Jul 26	0.03
Jul 26	0.04
Jun 26	0.06
Jun 26	0.08
Jun 26	0.06
Jun 26	0.05
May 26	0.05
May 26	0.05
May 26	0.06
Aug 25	8.34
Jul 25	8.99
Jul 25	6.38
Jul 25	6.5
Jul 25	5.67
Jun 25	5.14
Jun 25	4.49
Jun 25	4.78
Jun 25	4.6
May 25	4.14
May 25	4.49
May 25	4.08
May 25	65.1
May 25	71.38
Apr 25	60.53
Apr 25	65.76
Apr 25	64.15
Apr 25	80.71
Mar 25	204.09
Mar 25	233.44
Mar 25	220.96
Mar 25	237.82
Feb 25	233.77
Feb 25	223.99
Feb 25	282.69
Feb 25	371.74
Jan 25	310.35
Jan 25	273.58
Jan 25	244.57
Jan 25	229.73
Jan 25	267.51
Dec 24	235.46
Dec 24	199.7
Dec 24	208.47
Dec 24	229.05
Nov 24	231.33
Nov 24	229.22
Nov 24	226.02
Nov 24	84.28
Nov 24	77.21
Oct 24	75.11
Oct 24	57.44
Oct 24	58.2
Oct 24	59.65
Sep 24	59.09
Sep 24	63.95
Sep 24	65.28
Sep 24	66.27
Aug 24	64.62
Aug 24	66.38
Aug 24	67.49
Aug 24	64.62
Aug 24	124.59
Jul 24	145.81
Jul 24	142.75
Jul 24	157.96
Jul 24	145.71
Jun 24	149.72
Jun 24	114.03
Jun 24	125.86
Jun 24	138.74
May 24	141.91
May 24	137.51
May 24	138.32
May 24	124.71
May 24	126.65
Apr 24	113.86
Apr 24	119.1
Apr 24	130.13
Apr 24	137.36
Mar 24	90.55
Mar 24	90.78
Mar 24	85.55
Mar 24	85.21
Mar 24	83.28
Feb 24	80.21
Feb 24	80.55
Feb 24	83.73
Feb 24	79.08
Jan 24	80.89
Jan 24	84.3
Jan 24	91.46

No video analysis for this stock yet. Request one from our team.

News: KALA

globenewswire.com · 3 Sep 2026

Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Agreement Grants Kala Exclusive U.S. Rights to Market and Distribute Virotek's Ophthalmology Genomic Testing Program Agreement Grants Kala Exclusive U.S. Rights to Market and Distribute Virotek's Ophthalmology Genomic Testing Program

globenewswire.com · 1 Sep 2026

Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

ARLINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and Virotek Inc. ("Virotek"), a CLIA-registered precision health and clinical genomics company, today announced that they have entered into a letter of intent (the "LOI") outlining the principal terms under which the companies intend to negotiate a definitive agreement appointing Kala as the exclusive distributor and reseller in the United States of Virotek's genetic testing and screening program for ophthalmological indications.

defenseworld.net · 30 Jul 2026

KALA BIO (KALA) Expected to Post Earnings on Thursday

KALA BIO (NASDAQ: KALA - Get Free Report) is anticipated to release its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect KALA BIO to post earnings of ($6.00) per share for the quarter. Parties can find conference call details on the company's upcoming Q2 2026 earning report for the latest details